APOTHEEK R. REBRY: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
APOTHEEK R. REBRY
Largest movements
- Receivables within one year +€22,390
up €22,390 (+16.5%), from €135,807 to €158,197
of which Trade receivables: +€12,012
- Current investments -€19,704
down €19,704 (-50.1%), from €39,290 to €19,586
- Cash +€13,961
up €13,961 (+26.8%), from €52,081 to €66,042
mainly Net result for the year (+€24,684) and Depreciation (+€22,061)
- Tangible fixed assets -€12,346
down €12,346 (-13.3%), from €93,033 to €80,687
of which Land and buildings: -€8,767
- Reserves +€24,684
up €24,684 (+22.2%), from €111,403 to €136,087
of which Distributable reserves: +€24,684
- Debts after one year -€17,191
down €17,191 (-31.6%), from €54,331 to €37,140
- Trade debts +€11,463
up €11,463 (+10.0%), from €114,781 to €126,244
- Short-term financial debts -€9,833
down €9,833 (-8.4%), from €116,666 to €106,833
- Gross operating margin -€19,655
down €19,655 (-4.5%), from €438,927 to €419,272
- Financial charges -€7,351
down €7,351 (-38.0%), from €19,333 to €11,982
- Depreciation -€6,268
down €6,268 (-22.1%), from €28,329 to €22,061
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €505,965 | €511,831 | +€5,866 | +1.2% |
| Fixed assets | 21/28 | €93,068 | €80,722 | -€12,346 | -13.3% |
| Tangible fixed assets | 22/27 | €93,033 | €80,687 | -€12,346 | -13.3% |
| Land and buildings | 22 | €67,695 | €58,929 | -€8,767 | -13.0% |
| Plant, machinery and equipment | 23 | €20,318 | €17,482 | -€2,835 | -14.0% |
| Furniture and vehicles | 24 | €5,020 | €4,276 | -€744 | -14.8% |
| Financial fixed assets | 28 | €34 | €34 | = | 0.0% |
| Current assets | 29/58 | €412,897 | €431,109 | +€18,212 | +4.4% |
| Stocks and contracts in progress | 3 | €175,890 | €175,416 | -€474 | -0.3% |
| Stocks | 30/36 | €175,890 | €175,416 | -€474 | -0.3% |
| Amounts receivable within one year | 40/41 | €135,807 | €158,197 | +€22,390 | +16.5% |
| Trade receivables | 40 | €93,908 | €105,921 | +€12,012 | +12.8% |
| Other amounts receivable | 41 | €41,898 | €52,276 | +€10,377 | +24.8% |
| Current investments | 50/53 | €39,290 | €19,586 | -€19,704 | -50.1% |
| Cash at bank and in hand | 54/58 | €52,081 | €66,042 | +€13,961 | +26.8% |
| Deferred charges and accrued income | 490/1 | €9,829 | €11,867 | +€2,039 | +20.7% |
| Total equity and liabilities | 10/49 | €505,965 | €511,831 | +€5,866 | +1.2% |
| Equity | 10/15 | €136,193 | €160,876 | +€24,684 | +18.1% |
| Contributions | 10/11 | €24,789 | €24,789 | = | 0.0% |
| Reserves | 13 | €111,403 | €136,087 | +€24,684 | +22.2% |
| Tax-exempt reserves | 132 | €51,125 | €51,125 | = | 0.0% |
| Distributable reserves | 133 | €60,278 | €84,962 | +€24,684 | +40.9% |
| Profit (loss) carried forward | 14 | €0 | - | = | |
| Amounts payable | 17/49 | €369,772 | €350,954 | -€18,818 | -5.1% |
| Amounts payable after more than one year | 17 | €54,331 | €37,140 | -€17,191 | -31.6% |
| Financial debts | 170/4 | €54,331 | €37,140 | -€17,191 | -31.6% |
| Amounts payable within one year | 42/48 | €313,941 | €311,359 | -€2,582 | -0.8% |
| Current portion of amounts payable after more than one year | 42 | €19,289 | €17,191 | -€2,098 | -10.9% |
| Financial debts | 43 | €116,666 | €106,833 | -€9,833 | -8.4% |
| Credit institutions | 430/8 | €116,666 | €106,833 | -€9,833 | -8.4% |
| Trade debts | 44 | €114,781 | €126,244 | +€11,463 | +10.0% |
| Suppliers | 440/4 | €114,781 | €126,244 | +€11,463 | +10.0% |
| Taxes, remuneration and social security | 45 | €63,204 | €61,092 | -€2,113 | -3.3% |
| Taxes | 450/3 | €6,975 | €3,223 | -€3,752 | -53.8% |
| Remuneration and social security | 454/9 | €56,229 | €57,868 | +€1,639 | +2.9% |
| Accrued charges and deferred income | 492/3 | €1,501 | €2,455 | +€954 | +63.6% |
| Remuneration, social security and pensions | 62 | €341,801 | €345,000 | +€3,199 | +0.9% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €28,329 | €22,061 | -€6,268 | -22.1% |
| Other operating charges | 640/8 | €6,796 | €6,908 | +€112 | +1.6% |
| Non-recurring operating charges | 66A | €0 | €1,500 | +€1,500 | |
| Gross operating margin | 9900 | €438,927 | €419,272 | -€19,655 | -4.5% |
| Operating profit (loss) | 9901 | €62,000 | €43,803 | -€18,198 | -29.4% |
| Financial income | 75/76B | €2,421 | €3,552 | +€1,132 | +46.7% |
| Recurring financial income | 75 | €2,421 | €3,552 | +€1,132 | +46.7% |
| Financial charges | 65/66B | €19,333 | €11,982 | -€7,351 | -38.0% |
| Recurring financial charges | 65 | €19,333 | €11,982 | -€7,351 | -38.0% |
| Profit (loss) for the period before taxes | 9903 | €45,088 | €35,373 | -€9,716 | -21.5% |
| Income taxes | 67/77 | €9,464 | €10,689 | +€1,225 | +12.9% |
| Profit (loss) for the period | 9904 | €35,625 | €24,684 | -€10,941 | -30.7% |
| Profit (loss) for the period to be appropriated | 9905 | €35,625 | €24,684 | -€10,941 | -30.7% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 14 October 2026 via checked.be.